240 related articles for article (PubMed ID: 2952381)
1. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
Volk HD; Diamantstein T
Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
[TBL] [Abstract][Full Text] [Related]
2. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
3. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
[TBL] [Abstract][Full Text] [Related]
4. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
Smolen JS; Siminovitch K; Luger TA; Steinberg AD
Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
[TBL] [Abstract][Full Text] [Related]
5. "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.
Pawelec G; Brocker T; Busch FW; Bühring HJ; Fernandez N; Schneider EM; Wernet P
J Mol Cell Immunol; 1988; 4(1):21-34. PubMed ID: 2977949
[TBL] [Abstract][Full Text] [Related]
6. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
Huang YP; Miescher PA; Zubler RH
J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.
Takada S; Ueda Y; Suzuki N; Murakawa Y; Hoshino T; Green I; Steinberg AD; Horwitz DA; Sakane T
Eur J Immunol; 1985 Mar; 15(3):262-7. PubMed ID: 3156746
[TBL] [Abstract][Full Text] [Related]
9. Studies of immune abnormalities in systemic lupus erythematosus.
Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
[TBL] [Abstract][Full Text] [Related]
11. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
[TBL] [Abstract][Full Text] [Related]
12. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
Otsuka T; Okamura S; Niho Y; Kusaba T
J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
[TBL] [Abstract][Full Text] [Related]
13. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
[TBL] [Abstract][Full Text] [Related]
14. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T
J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529
[TBL] [Abstract][Full Text] [Related]
16. T cell subsets in patients with systemic lupus erythematosus.
Kucharz EJ; Sierakowski SJ
Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
[TBL] [Abstract][Full Text] [Related]
17. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
Alcocer-Varela J; Laffon A; Alarcón-Segovia D
Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371
[TBL] [Abstract][Full Text] [Related]
18. Cellular interactions in the human T-T autologous mixed lymphocyte reaction.
Gupta S
Behring Inst Mitt; 1983 May; (72):101-6. PubMed ID: 6242329
[TBL] [Abstract][Full Text] [Related]
19. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
